Dr. Boris Stoeber (right), professor at University of British Columbia, is redefining drug delivery through the
development of painless, hollow metal microneedle arrays that barely penetrate the skin. More recently,
he and his team have integrated optical sensing properties into these arrays, offering a faster, cheaper and
less invasive alternative to hypodermic-based blood sampling for drug monitoring. Founder of microneedle
startup Microdermics, he is shown here with company co-founder Iman Mansoor (centre) and Dr. Mehrsa
Raeiszadeh (left), Microdermics employee.